About hemophilia A
Hemophilia is a rare bleeding disorder caused by deficiency of clotting factors such as VIII and IX. It is an X-linked recessive disorder, which is more prevalent in males than in females. It is estimated that it affects around 400,000 people per year. The two major types of hemophilia are A and B. Hemophilia A, also called as classical hemophilia or factor VIII deficiency hemophilia, is caused by deficiency of clotting factor VIII. It is transmitted genetically from parent to child during birth. Recombinant clotting factors or plasma-derived clotting factors are being developed for the treatment of this disorder.
Analysts forecast the global hemophilia A drugs market to grow at a CAGR of 6.25% over the period 2014-2019.
To Browse a Full Report with TOC@ http://www.researchmoz.us/global-hemophilia-a-market-2015-2019-report.html
Covered in this report
The report covers the current scenario and the growth prospects of the global hemophilia A drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment and prevention of hemophilia A. In this report, the market is also segmented based on the type of therapy.
Report, Global Hemophilia A Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, and Americas; it also covers the landscape of the global hemophilia A drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=386510
Key regions
Americas
APAC
Europe
Key vendors
Baxter International
Bayer's
CSL Behring
Novo Nordisk
Pfizer
Other prominent vendors
Alnylam Pharmaceuticals
Amarna Therapeutics
Asklepios
Biogen Idec
Catalyst Biosciences
Dimension Therapeutics
Dong-A Socio
Emergent BioSolutions
Grifols
Inspiration Biopharmaceuticals
Kedrion Biopharma
Octapharma
OPKO Health
rEVO Biologics
Sangamo BioSciences
Spark Therapeutics
UniQure
Market driver
Development of drugs with prolonged action
For a full, detailed list, view our report
Market challenge
High cost of therapy
For a full, detailed list, view our report
Market trend
Advances in technology
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=enquiry&repid=386510
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Hemophilia is a rare bleeding disorder caused by deficiency of clotting factors such as VIII and IX. It is an X-linked recessive disorder, which is more prevalent in males than in females. It is estimated that it affects around 400,000 people per year. The two major types of hemophilia are A and B. Hemophilia A, also called as classical hemophilia or factor VIII deficiency hemophilia, is caused by deficiency of clotting factor VIII. It is transmitted genetically from parent to child during birth. Recombinant clotting factors or plasma-derived clotting factors are being developed for the treatment of this disorder.
Analysts forecast the global hemophilia A drugs market to grow at a CAGR of 6.25% over the period 2014-2019.
To Browse a Full Report with TOC@ http://www.researchmoz.us/global-hemophilia-a-market-2015-2019-report.html
Covered in this report
The report covers the current scenario and the growth prospects of the global hemophilia A drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment and prevention of hemophilia A. In this report, the market is also segmented based on the type of therapy.
Report, Global Hemophilia A Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, and Americas; it also covers the landscape of the global hemophilia A drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=386510
Key regions
Americas
APAC
Europe
Key vendors
Baxter International
Bayer's
CSL Behring
Novo Nordisk
Pfizer
Other prominent vendors
Alnylam Pharmaceuticals
Amarna Therapeutics
Asklepios
Biogen Idec
Catalyst Biosciences
Dimension Therapeutics
Dong-A Socio
Emergent BioSolutions
Grifols
Inspiration Biopharmaceuticals
Kedrion Biopharma
Octapharma
OPKO Health
rEVO Biologics
Sangamo BioSciences
Spark Therapeutics
UniQure
Market driver
Development of drugs with prolonged action
For a full, detailed list, view our report
Market challenge
High cost of therapy
For a full, detailed list, view our report
Market trend
Advances in technology
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=enquiry&repid=386510
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
No comments:
Post a Comment